BayBridge Capital Group’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,887	Closed	-$555K	–	99
2024 Q2	$555K	Buy	3,887 +77	+2%	+$11K	0.43%	54
2024 Q1	$477K	Sell	3,810 -381	-9%	-$47.7K	0.42%	60
2023 Q4	$449K	Buy	+4,191	New	+$449K	0.42%	55